Pine Pharmacy
Outcome
DEA revoked Pine Pharmacy's DEA Certificate of Registration No. FS1451222 effective February 17, 2026, for repeatedly filling Schedule II-V controlled substance prescriptions from March 2023 through December 2024 without addressing, resolving, or documenting red flags including long travel distances, drug cocktails, and high-dose opioids.
Details
Pine Pharmacy — DEA Revocation for 21-Month Pattern of Unresolved Red Flags (2023–2026)
Outcome: DEA revoked Pine Pharmacy's DEA Certificate of Registration No. FS1451222, effective February 17, 2026, after finding that from March 2023 through December 2024 — a 21-month period — the pharmacy repeatedly filled Schedule II through V controlled substance prescriptions without addressing, resolving, or documenting the resolution of multiple red flags of abuse and diversion, in violation of federal and Florida state law.
Pine Pharmacy was a Florida pharmacy that held DEA Certificate of Registration No. FS1451222. The DEA's investigation found that from March 2023 through December 2024, the pharmacy repeatedly filled controlled substance prescriptions that evidenced multiple red flags indicative of diversion and/or abuse without taking any documented steps to address or resolve those flags before dispensing.
The specific red flags identified included: filling prescriptions for individuals whose addresses indicated they had traveled abnormally long distances to obtain and fill their controlled substance prescriptions — a classic geographic outlier indicator; dispensing so-called "drug cocktails" — combinations of controlled substances that are widely known to be abused or diverted and that, taken together, significantly increase overdose risk; and issues related to high dosages and extended-use opioids.
These violations continued as recently as December 5, 2024. The DEA revoked the registration, denied any pending renewal or modification applications, and denied any pending applications for additional DEA registration in Florida, with the order effective February 17, 2026. The Decision and Order was published in the Federal Register on January 15, 2026.
Primary Source: Pine Pharmacy; Decision and Order (Fed. Reg. Jan. 15, 2026)
How Crucible Prevents This
Pine Pharmacy filled controlled substance prescriptions for patients traveling abnormally long distances and for drug cocktail combinations across a 21-month period without any documentation of red-flag resolution. Crucible's geographic outlier detection and drug cocktail alerts, both with mandatory pre-dispensing documentation requirements, would have generated alerts on the first occurrence rather than allowing the pattern to persist for nearly two years.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works